Cash & equivalents increased 73.7%
Cash & equivalents changed +73.7% from the comparable as-filed period.
Ranked by interpretable importance, issuer history, magnitude, and accounting profile. No directional recommendation.
Cash & equivalents changed +73.7% from the comparable as-filed period.
Net income changed +29.1% from the comparable as-filed period.
Operating income changed +31.0% from the comparable as-filed period.
Revenue changed +14.5% from the comparable as-filed period.
Operating margin moved +1.43 percentage points from the comparable as-filed period.
Research & development changed +4.2% from the comparable as-filed period.
Selling, general & administrative changed +5.4% from the comparable as-filed period.
Inventory changed +2.8% from the comparable as-filed period.
Method Importance combines metric-family relevance, magnitude, issuer-history unusualness, persistence, and financial-statement significance. It is analytical prioritization, not a legal materiality conclusion or investment signal.